Back
Pan American Silver Corp. Vs. Nektar Therapeutics Industry Stock Comparison
Buy
94
PAAS.TO
Pan American Silver Corp.
Last Price:
$68.41
Seasonality Move:
7.64%
Sell
33
NKTR
Nektar Therapeutics
Last Price:
$54.70
Seasonality Move:
11.58%
Buy
94
Pan American Silver Corp. (PAAS.TO)
is a Buy
Is Pan American Silver Corp. a Buy, Sell or Hold?
-
The current Pan American Silver Corp. [PAAS.TO] share price is $69.36. The Score for PAAS.TO is 94, which is 88% above its historic median score of 50, and infers lower risk than normal.
-
PAAS.TO is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
33
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PAAS.TO Stock Price Chart
What is Pan American Silver Corp.'s stock price today?
-
The Pan American Silver Corp. share price today is $69.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PAAS.TO is experiencing slight selling pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $51.12The current trend is relatively stagnant and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
PAAS.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.74 | Buy |
| Relative Strength Index (14 RSI): | 73.74 | Buy |
| Chaikin Money Flow: | -62018 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.4 - 63.6) | Buy |
| Bollinger Bands (100): | (43.61 - 57.35) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 39.75 | Sell |
| Chaikin Money Flow: | -893008 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.73 - 61.07) | Sell |
| Bollinger Bands (100): | (32.3 - 62.42) | Buy |
PAAS.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.95 | Buy |
| 20-day SMA: | 59.37 | Buy |
| 50-day SMA: | 55.06 | Buy |
| 200-day SMA: | 43.51 | Buy |
| 8-day EMA: | 64.6 | Buy |
| 20-day EMA: | 60.56 | Buy |
| 50-day EMA: | 55.88 | Buy |
| 200-day EMA: | 45.61 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.44 | Sell |
| 20-day SMA: | 58.08 | Sell |
| 50-day SMA: | 58.52 | Sell |
| 200-day SMA: | 30.43 | Buy |
| 8-day EMA: | 56.58 | Sell |
| 20-day EMA: | 57.71 | Sell |
| 50-day EMA: | 55.82 | Sell |
| 200-day EMA: | 37.69 | Buy |
Pan American Silver Corp. Earnings Growth & PAAS.TO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.82 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.87 per share, and an increase next year of $1.98 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
Pan American Silver Corp. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||